Group One Trading
CLGN icon

Group One Trading’s CollPlant Biotechnologies CLGN Stock Holding History

Group One Trading’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$749 Hold
1,400
– – ﹤0.01% 7262
2025
Q4 		$1.97K Buy
1,400
+1,300
+1,300% +$2.66K ﹤0.01% 7555
2025
Q3 		$269 Buy
+100
New +$238 ﹤0.01% 8198

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Group One Trading's CLGN Position: Q1 2026 in Review

Group One Trading reduced its CollPlant Biotechnologies (CLGN) stake by 71% in Q1 2026, selling an estimated $3.53K and leaving 1,400 shares worth $749. The position accounts for ﹤0.01% of the portfolio, ranked #7261.

Group One Trading first reported a position in CLGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $13.4K in Q3 2025. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

  • Group One Trading held 1,400 shares of CollPlant Biotechnologies worth $749 as of Q1 2026.
  • Group One Trading sold 3,500 CollPlant Biotechnologies shares in Q1 2026, an estimated $3.53K.
  • CollPlant Biotechnologies made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7261 holding.
  • Group One Trading first reported a position in CollPlant Biotechnologies in Q3 2025 and has held it in 3 quarters since.
  • Group One Trading's CollPlant Biotechnologies position peaked at $13.4K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.